Maternal health among Venezuelan women migrants at the border of Brazil L Bahamondes, M Laporte, D Margatho, HSF de Amorim, C Brasil, ... BMC Public Health 20, 1-8, 2020 | 50 | 2020 |
One‐year follow up on post‐placental IUD insertion: A randomized clinical trial M Marangoni Jr, M Laporte, F Surita, MB Kraft, L Bahamondes, ... Acta obstetricia et gynecologica Scandinavica 100 (4), 596-603, 2021 | 20 | 2021 |
Evaluation of clinical performance when intrauterine devices are inserted by different categories of healthcare professional M Laporte, A Becerra, L Castro, N Veiga Jr, X Espejo‐Arce, ... International Journal of Gynecology & Obstetrics 152 (2), 196-201, 2021 | 17 | 2021 |
Postplacental placement of intrauterine devices: A randomized clinical trial M Laporte, M Marangoni Jr, F Surita, CT Juliato, M Miadaira, ... Contraception 101 (3), 153-158, 2020 | 17 | 2020 |
Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil M Laporte, S Metelus, M Ali, L Bahamondes International Journal of Gynecology & Obstetrics 156 (2), 240-246, 2022 | 7 | 2022 |
Reasons for satisfaction with the use of the 52‐mg levonorgestrel intrauterine system M Laporte, CM Charles, S Metelus, RB Souza, A Peloggia, ... International Journal of Gynecology & Obstetrics 159 (2), 577-582, 2022 | 3 | 2022 |
Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system M Laporte, A Peloggia, AC Marcelino, LS de Carvalho, L Bahamondes The European Journal of Contraception & Reproductive Health Care 27 (3), 208-211, 2022 | 2 | 2022 |
Uptake, discontinuation, and continuation rate of long-acting contraceptive methods when offered at no cost in Campinas, Brazil M Laporte, AC Marcelino, P da Cunha Pereira, X Espejo-Arce, CT Juliato, ... Contraception 132, 110363, 2024 | 1 | 2024 |
Single‐visit long‐acting reversible contraception provision and pregnancy rates within 3 months SI Manhiça, L Bahamondes, M Laporte, F Anjos, M Viscola, E Garcia, ... International Journal of Gynecology & Obstetrics 161 (3), 1028-1032, 2023 | 1 | 2023 |
Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method M Laporte, CM Charles, S Metelus, A Peloggia, GO Paez, CT Juliato, ... International Journal of Gynecology & Obstetrics 158 (3), 700-704, 2022 | 1 | 2022 |
Barriers to accessing post-pregnancy contraception in Brazil: The impact of COVID-19 CRT Juliato, M Laporte, F Surita, L Bahamondes Best Practice & Research Clinical Obstetrics & Gynaecology, 102482, 2024 | | 2024 |
Effectiveness and continuation rates of the etonogestrel‐subdermal contraceptive implant versus short‐acting contraceptive methods offered at no cost in Campinas, Brazil M Laporte, AC Marcelino, P da Cunha Pereira, X Espejo‐Arce, CT Juliato, ... International Journal of Gynecology & Obstetrics, 2024 | | 2024 |
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition JBE Versailles, S Metelus, A Peloggia, M Laporte, L Bahamondes, ... The European Journal of Contraception & Reproductive Health Care 28 (4), 207-209, 2023 | | 2023 |
ASPECTOS CLÍNICOS DO USO E DA INSERÇÃO DO DISPOSITIVO INTRAUTERINO HORMONAL (52 mg) E DO DISPOSITIVO INTRAUTERINO COM COBRE (DIU-TCu380A) M Laporte | | |